An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)
Launched by SURGIFY MEDICAL OY · Feb 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new medical device called Surgify Halo™ to see how well it works in spine surgery compared to a commonly used tool known as the Rosen burr. The main goals are to evaluate how easy the Surgify Halo™ is to use and how effectively it cuts through bone during surgery. The researchers plan to enroll 30 participants who need surgery on their spine or head that involves removing bone.
To be eligible for this study, participants should be between the ages of 21 and 85 and must have a condition that requires surgical treatment involving bone removal. They also need to be able to understand and agree to the study's purpose and risks. However, people who have had previous surgery in the area being treated, have certain bone conditions, or are in vulnerable situations (like being pregnant or having difficulty making decisions) cannot participate. If you join the study, you can expect to help researchers learn more about this new device, which could improve spine surgery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Disease of the spine or head requiring surgery with bone removal
- • Ability to understand the purpose and risks of the study and to give written informed consent
- • Age 21-85 years
- Exclusion Criteria:
- • Previous surgery in the same area
- • Abnormalities of bone tissue
- • Vulnerable patients (such as prisoners, Individuals with limited or no reading skills, decisionally impaired persons, persons in nursing homes, patients in emergency), and pregnant women
- • Allergy or hypersensitivity to medical-grade stainless steel or any alloying components
- • Problems with blood clotting
About Surgify Medical Oy
Surgify Medical Oy is an innovative medical technology company dedicated to advancing surgical procedures through the development of cutting-edge solutions that enhance precision and safety in the operating room. With a focus on minimizing risks and improving patient outcomes, Surgify Medical Oy leverages advanced engineering and clinical expertise to create products that support healthcare professionals in delivering effective surgical care. The company is committed to rigorous clinical research, ensuring that its offerings meet the highest standards of efficacy and regulatory compliance, thereby contributing to the evolution of modern surgical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York City, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported